Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Dual-Readout mRNA for Translational Delivery Science
2026-08-12
A thought-leadership guide to using dual fluorescent and bioluminescent readouts to separate mRNA delivery, intracellular trafficking, stability, and functional translation. The article positions EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) as a strategic reporter for optimizing carriers and making translational decisions.
-
Integrated iPSC-Cardiomyocyte Data for Risk
2026-08-12
Tsai and colleagues combine functional phenotyping, cytotoxicity testing, and whole-transcriptome analysis in human iPSC-derived cardiomyocytes to evaluate chemical cardiotoxicity across 464 substances. Their results show that transcriptomic and phenotypic points of departure can support complementary hazard prioritization, mechanistic interpretation, and exposure-based risk characterization.
-
Indazole and Indole Glucagon Receptor Antagonists
2026-08-11
The 2015 study reported a potent indazole- and indole-based series of glucagon receptor antagonists designed from the earlier MK-0893 scaffold. Its structure–activity relationship analysis identified compounds with strong in vitro activity and rat pharmacokinetic profiles, while GRA 16d showed oral activity in acute glucagon-challenge and diabetic mouse models.
-
Perospirone Workflows for Receptor and Kv1.5 Studies
2026-08-11
Perospirone enables a two-layer research strategy: receptor pharmacology for serotonergic and dopaminergic signaling pathways, followed by functional testing of vascular Kv1.5 channel effects. This guide translates its dual profile into practical assay workflows, controls, and troubleshooting steps for schizophrenia research and neurovascular studies.
-
Protease Inhibitor Cocktail for METTL3 Workflows
2026-08-10
Protect labile signaling proteins during lysis, Western blotting, co-immunoprecipitation, and kinase assays with a broad-spectrum formulation that combines DMSO-dissolved inhibitors with separate EDTA. This workflow-focused guide shows how to preserve degradation-sensitive targets such as HSP90 clients and METTL3 while avoiding EDTA-related interference in metal-affinity workflows.
-
Anti-Resistance AR Antagonists: Study Insights
2026-08-09
The reference study identifies a benzo[b]oxepine-based androgen receptor antagonist that targets the AR dimer interface rather than the conventional ligand-binding pocket. Its lead compound, Y5, combines AR dimerization disruption with ubiquitin–proteasome-mediated receptor degradation and retains activity against several drug-resistant AR variants, supporting a distinct strategy for castration-resistant prostate cancer.
-
Mithramycin A Research Workflows
2026-08-08
Mithramycin A is an anticancer antibiotic for probing G-C-rich transcription, c-myc regulation, and myeloid differentiation in controlled cell-based assays. This guide converts its mechanism into practical dose-response, leukemia, and pathway-validation workflows while clarifying how a recent cardiac study can inform—not validate—cross-domain experiments.
-
Laminin (925-933) as an ECM Signal Probe
2026-08-07
Laminin (925-933) is a defined Laminin B1 chain peptide for separating receptor-level adhesion and chemotaxis signals from complex extracellular matrix effects. This article connects peptide-based assays with the collagen-VI-enriched organoid niche described in a 2025 Cell Stem Cell study.
-
COX Inhibitors Suppress Canine Mammary Tumor Cell Growth In
2026-08-07
This study demonstrates that piroxicam and deracoxib, used separately or in combination, inhibit proliferation and induce apoptosis in canine mammary carcinoma cells. These findings highlight the potential of combined COX inhibition as a novel therapeutic strategy for canine mammary tumors, informing future translational research in comparative oncology.
-
Lamotrigine: Mechanisms and CNS Research Utility (B2249)
2026-08-06
Lamotrigine, also known as 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, is a clinically relevant anticonvulsant and sodium channel blocker with well-documented roles in CNS and cardiac research. Its high purity, confirmed by HPLC and NMR, enables reproducible studies on sodium and serotonin signaling. New blood-brain barrier models further clarify its permeability and experimental use.
-
Applied Use-Cases for Alcian Blue & Nuclear Fast Red Stainin
2026-08-06
The Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5, from APExBIO enables reproducible mucopolysaccharide detection and nuanced chondrogenic differentiation workflows. Learn how its dual-staining chemistry streamlines tissue analysis, with troubleshooting and protocol tips refined by recent research.
-
Bufalin in Cancer Research: Mechanistic Insights and Next-Ge
2026-08-05
Explore the multifaceted role of Bufalin as a cardiotonic steroid in advanced cancer research. This article delivers novel mechanistic insights, with a focus on apoptosis induction and molecular glue degradation, offering scientists actionable strategies for robust experimental design.
-
HOXC8 Regulates Pyroptosis in NSCLC via Caspase-1 Suppressio
2026-08-05
This study reveals that HOXC8, a transcription factor frequently overexpressed in non-small cell lung carcinoma, inhibits pyroptotic cell death by repressing caspase-1 expression. The findings clarify a non-canonical mechanism of pyroptosis regulation in lung cancer, with implications for targeting tumor cell survival pathways.
-
Adiponectin Attenuates Cognitive Deficits via TLR4/NF-κB Inh
2026-08-04
This study demonstrates that adiponectin treatment mitigates splenectomy-induced cognitive decline in aged rats by suppressing neuroinflammation and oxidative stress through the TLR4/MyD88/NF-κB pathway. These insights clarify mechanisms underlying perioperative neurocognitive disorder and highlight peptide-based interventions as promising research avenues.
-
Meropenem: β-Lactam Antibiotic Carbapenem for Reliable Assay
2026-08-04
Meropenem, a β-lactam antibiotic carbapenem from APExBIO, empowers researchers tackling Gram-negative and Gram-positive bacterial models. This guide demystifies protocol optimization, troubleshooting, and advanced resistance research workflows using Meropenem (SKU A5124).